Yale Medicine School: Changing the Lives of Patients With Alopecia and Vitiligo
May 18, 2023
May 18, 2023
NEW HAVEN, Connecticut, May 18 (TNSres) -- Yale School of Medicine issued the following news:
* * *
Meet the Dermatologist Who Advocated for the First FDA-Approved Treatments for Both
* * *
In June 2014, the publication of a new paper stirred enormous excitement around the world. Using tofacitinib citrate, an FDA-approved drug for rheumatoid arthritis, Brett King, MD, PhD, associate professor of dermatology, gave Kyle Rhodes, a 25 year old stru . . .
* * *
Meet the Dermatologist Who Advocated for the First FDA-Approved Treatments for Both
* * *
In June 2014, the publication of a new paper stirred enormous excitement around the world. Using tofacitinib citrate, an FDA-approved drug for rheumatoid arthritis, Brett King, MD, PhD, associate professor of dermatology, gave Kyle Rhodes, a 25 year old stru . . .